Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 19, 2015 - Issue 3
Submit an article Journal homepage
1,693
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment

Athanasios D Anastasilakis424 General Military Hospital, Endocrinology, Ring Road, N.Efkarpia, Thessaloniki, 56429, [email protected]
,
Stergios A PolyzosAristotle University of Thessaloniki, Medical School, Second Medical Clinic, Simou Lianidi 13, Thessaloniki, Greece
,
Polyzois Makras251 Hellenic Air Force and VA General Hospital, Endocrinology and Diabetes, Athens, Greece
,
Athina Gkiomisi424 General Military Hospital, Gynaecology, Thessaloniki, Greece
,
Grigorios Sakellariou424 General Military Hospital, Rheumatology, Thessaloniki, Greece
,
Matthaios Savvidis424 General Military Hospital, Orthopedics, Thessaloniki, Greece
,
Athanasios Papatheodorou251 Hellenic Air Force and VA General Hospital, Medical Research, Athens, Greece
,
Panagiotis Kokkoris251 Hellenic Air Force and VA General Hospital, Endocrinology and Diabetes, Athens, Greece
&
Evangelos TerposUniversity of Athens, School of Medicine, Department of Clinical Therapeutics, 5 Marathonomahnon street, Drosia Attikis, Athens, 14572, Greece
 show all
Pages 299-306 | Published online: 14 Nov 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mingfu Wu, Jing Li, Qinglei Gao & Fei Ye. (2016) The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases. Expert Opinion on Therapeutic Targets 20:7, pages 885-901.
Read now

Articles from other publishers (14)

Zhenen Lin, Guanshu Yu, Shengren Xiong, Yu Lin & Zhaohui Li. (2023) Leptin and melatonin’s effects on OVX rodents’ bone metabolism. Frontiers in Endocrinology 14.
Crossref
Hao Xu, Wentao Wang, Xin Liu, Wei Huang, Chen Zhu, Yaozeng Xu, Huilin Yang, Jiaxiang Bai & Dechun Geng. (2023) Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Hong Mu, Ying Pang, Lili Liu, Jingbo Liu & Chunsheng Liu. (2023) Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw. European Journal of Medical Research 28:1.
Crossref
Lichen Ji, Wei Zhang, Xugang Zhong, Tingxiao Zhao, Xixi Sun, Senbo Zhu, Yu Tong, Junchao Luo, Youjia Xu, Di Yang, Yao Kang, Jin Wang & Qing Bi. (2022) Osteoporosis, fracture and survival: Application of machine learning in breast cancer prediction models. Frontiers in Oncology 12.
Crossref
Diana Ovejero, Natalia Garcia-Giralt, Núria Martínez-Gil, Raquel Rabionet, Susanna Balcells, Daniel Grinberg, Luis Alberto Pérez-Jurado, Xavier Nogués & Iñigo Etxebarria-Foronda. (2022) Clinical description and genetic analysis of a novel familial skeletal dysplasia characterized by high bone mass and lucent bone lesions. Bone 161, pages 116450.
Crossref
Xenia G. Borggaard, Malene H. Nielsen, Jean-Marie Delaisse, Christina M. Andreasen & Thomas L. Andersen. (2022) Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites. Frontiers in Molecular Biosciences 9.
Crossref
Tatsuhiko Kuroda, Masataka Shiraki, Toshitaka Nakamura, Hiroaki Suzuki, Kazuki Hiraishi, Toshitsugu Sugimoto & Satoshi Tanaka. (2021) Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study. Calcified Tissue International 110:1, pages 87-92.
Crossref
Laith K. Hasan, Jihad Aljabban, Michael Rohr, Mohamed Mukhtar, Nikhil Adapa, Rahaf Salim, Nabeal Aljabban, Saad Syed, Sharjeel Syed, Maryam Panahiazar, Dexter Hadley & Wael Jarjour. (2021) Metaanalysis Reveals Genetic Correlates of Osteoporosis Pathogenesis. The Journal of Rheumatology 48:6, pages 940-945.
Crossref
Andy Göbel, Jan D. Kuhlmann, Theresa Link, Pauline Wimberger, Cornelia Link-Rachner, Stefanie Thiele, Stefania Dell'Endice, Giulia Furesi, Dorit Breining, Martina Rauner, Lorenz C. Hofbauer & Tilman D. Rachner. (2019) Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients. Journal of Bone Oncology 16, pages 100237.
Crossref
Konstantinos Lontos, Juraj Adamik, Anastasia Tsagianni, Deborah L. Galson, John M. Chirgwin & Attaya Suvannasankha. (2018) The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. Frontiers in Endocrinology 9.
Crossref
Tianliang Sun, Lida Yang, Harmandeep Kaur, Jenny Pestel, Mario Looso, Hendrik Nolte, Cornelius Krasel, Daniel Heil, Ramesh K. Krishnan, Marie-Josée Santoni, Jean-Paul Borg, Moritz Bünemann, Stefan Offermanns, Jakub M. Swiercz & Thomas Worzfeld. (2017) A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. Journal of Cell Biology 216:1, pages 199-215.
Crossref
David W. Dempster, Hua Zhou, Robert R. Recker, Jacques P. Brown, Christopher P. Recknor, E. Michael Lewiecki, Paul D. Miller, Sudhaker D. Rao, David L. Kendler, Robert Lindsay, John H. Krege, Jahangir Alam, Kathleen A. Taylor, Boris Janos & Valerie A. Ruff. (2016) Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study. The Journal of Clinical Endocrinology & Metabolism 101:4, pages 1353-1363.
Crossref
Polyzois Makras, Sideris Delaroudis & Athanasios D. Anastasilakis. (2015) Novel therapies for osteoporosis. Metabolism 64:10, pages 1199-1214.
Crossref
Lichen Ji, Wei Zhang, Xugang Zhong, Tingxiao Zhao, Xixi Sun, Senbo Zhu, Yu Tong, Junchao Luo, Youjia Xu, Di Yang, Yao Kang, Jin Wang & Qing Bi. (2022) Osteoporosis, Fracture and Survival: Application of Machine Learning in Breast Cancer Prediction Models. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.